Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9402680 | Journal of Surgical Research | 2005 | 6 Pages |
Abstract
Recombinant viral vectors such as vaccinia may be coated with biotin/avidin and linked to biotinylated antibodies to preferentially target specific cell types in vitro. Such an approach may be useful in targeting recombinant lytic viruses to tumors for destruction and in immune up-regulation in vivo. Similarly, this approach may enhance nonlytic viruses for gene therapy applications.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Benjamin M.D., Kevin M.D., Ph.D.,